Literature DB >> 18703886

Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.

Chima O Oluigbo1, Guirish A Solanki.   

Abstract

BACKGROUND: Recombinant human bone morphogenetic protein-2 (rhBMP-2) is a genetically engineered protein which recruits bone-forming cells to the surgical area and converts local cells to bone. In clinical studies, rhBMP-2 successfully enhanced anterior/posterior spinal fusions in adult humans without bone grafts. Efficacy in paediatric spinal fusion is not yet reported.
METHODS: We describe the surgical technique and results in a 2-year-old girl with unstable C1-2 cervical spine injury who underwent non-metal-instrumented C1/C2 posterior spinal fusion using rhBMP-2 applied to an absorbable collagen sponge (ACS) matrix.
RESULTS: Radiologically verifiable bony fusion began at 3 weeks. Within 8 weeks solid C1-C2 spinal fusion was confirmed by CT scan. There was no evidence of spinal canal encroachment and no adverse effects related to the rhBMP-2/ACS-carrier matrix.
CONCLUSION: rhBMP-2 enhanced posterior cervical fusion at an impressive rate in a very young child. This finding is encouraging both to effectiveness and speed. However, with all new developments, we highlight the need for further experience and longer follow-up in children. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703886     DOI: 10.1159/000149907

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  7 in total

1.  The use of recombinant human BMP-2 as a salvage procedure in the pediatric spine: a report on 3 cases.

Authors:  Kiril V Mladenov; Philip Kunkel; Ralf Stuecker
Journal:  Eur Spine J       Date:  2009-10-30       Impact factor: 3.134

Review 2.  Bone morphogenetic protein in pediatric spine fusion surgery.

Authors:  Robert W Molinari; Christine Kerr; Danielle Kerr
Journal:  J Spine Surg       Date:  2016-03

Review 3.  Vascularized Occipital Bone Grafting: Indications, Techniques, Clinical Outcomes, and Alternatives.

Authors:  Sebastian J Winocour; Erica Y Xue; Michael A Bohl; Farrokh Farrokhi; Matthew J Davis; Amjed Abu-Ghname; Alexander E Ropper; Edward M Reece
Journal:  Semin Plast Surg       Date:  2021-05-10       Impact factor: 2.314

4.  Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing.

Authors:  D Kojo Hamilton; Justin S Smith; Davis L Reames; Brian J Williams; Christopher I Shaffrey
Journal:  J Craniovertebr Junction Spine       Date:  2010-07

Review 5.  The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma.

Authors:  A S Herford
Journal:  Chin J Traumatol       Date:  2017-02-09

Review 6.  Spinal involvement in mucopolysaccharidosis IVA (Morquio-Brailsford or Morquio A syndrome): presentation, diagnosis and management.

Authors:  Guirish A Solanki; Kenneth W Martin; Mary C Theroux; Christina Lampe; Klane K White; Renée Shediac; Christian G Lampe; Michael Beck; William G Mackenzie; Christian J Hendriksz; Paul R Harmatz
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

7.  The Use of Bone Morphogenetic Protein in Pediatric Cervical Spine Fusion Surgery: Case Reports and Review of the Literature.

Authors:  Robert W Molinari; Christine Molinari
Journal:  Global Spine J       Date:  2015-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.